4.6% Above Target

Wall Street's consensus price target for CPT is $112.16, -4.6% from its current price of $117.58. The below-market target from 41 analysts suggests limited near-term appreciation.

CPT has a consensus rating of "Hold" based on 41 Wall Street analysts. The rating breakdown is mixed, with 20 Hold ratings making up the largest segment. The consensus 12-month price target of $112.16 implies -4.6% downside from current levels.

At a forward P/E of 71.8046x, CPT trades at a premium valuation. The consensus price target of $112.16 (-4.6% downside) suggests analysts may view current valuations as stretched.

The most bullish Wall Street analyst has a price target of $123 for CPT, while the most conservative target is $102. The consensus of $112.16 represents the median expectation. Our quantitative valuation model projects a bull case target of $128 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CPT is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 20 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CPT stock forecast based on 41 Wall Street analysts shows a consensus price target of $112.16, with estimates ranging from $102 (bear case) to $123 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $97, with bear/bull scenarios of $61/$128.

Our quantitative valuation model calculates CPT's fair value at $97 (base case), with a bear case of $61 and bull case of $128. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.

CPT trades at a forward P/E ratio of 71.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 33.2x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on CPT, with 3 Sell ratings and a price target of $112.16 (-4.6% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CPT analyst price targets range from $102 to $123, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $112.16 consensus represents the middle ground. Our model's $61-$128 range provides an independent fundamental perspective.